--Hansa Biopharma AB, "Hansa" today announced that it will host a virtual investor event on Guillain-Barré syndrome on Monday, June 16, 2025 at 14:00 CEST/ 8:00 AM EDT. David R. Cornblath, MD ...

Tama Matsuoka Wong transforms overlooked weeds into gourmet treasures for Michelin star chefs through the art of modern foraging.

The resurfacing of a 70-year-old disease has become a cause of public concern with 23,000 confirmed cases. Here is what you ...

Do we recommend GBS warranty services? Yes. GBS Enterprises’ warranty plans are a good idea for customers looking to protect their purchases.

Chhatrapati Sambhajinagar: A 22-year-old youth recovered from Guillain-Barré Syndrome (GBS) after an 96-day stay in Nanded's Dr Shankarrao Chavan Gove.

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding to expand its plasma ...

Know Labs shares soars Friday on news of its acquisition by an investor. The deal installs a new CEO and pivots the firm to a Bitcoin strategy. Market-moving news hits Benzinga Pro first—get a ...

While a handful of states have banned the sale or production of lab-grown meat within their borders, the infant industry is still innovating. Cultivated salmon company Wildtype received approval ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

The new lab, set to include the Scale AI founder Alexandr Wang, is part of a reorganization of Meta’s artificial intelligence efforts under Mark Zuckerberg.

The White House replaced the federal government’s hub for news and updates on COVID-19 with a website saying the virus leaked out of a Chinese lab.

Know Labs’ founder, Ron Erickson, will transition to the role of Vice Chairman of the Board and President of a new division focused on continuing the company’s proprietary diagnostic research.